Wednesday, May 2, 2018
6:45 - 8:15am
Hawaii Convention Center, Room 313BC
Van Lansingh, MD, PhD
Medical Officer for Latin America
Help Me See
Residency Training Director
Mexican Institute of Ophthalmology
How to Start your International Career and Contacts
Professor Lansingh has worked in Latin America, North America, South East Asia, and the Pacific. He obtained his MD in 1987 from the Universidad Nacional Autonoma de Mexico City, Mexico, with residency and postgraduate work in Mexico City (APEC/UNAM) and the Nielsen Center for Eye Surgery/University of South Florida. In 2005, he was awarded a PhD from the University of Melbourne, Melbourne, Australia in health sciences after field work with Aboriginal communities in Central Australia in which he studied the effects of the SAFE strategy for trachoma. After several posts in Mexico, Papua New Guinea, Australia, and Latin America (a former Academic and Research Advisor of Fundacion Vision, Paraguay 2003 - 2007), as well as the IAPB's VISION 2020 regional coordinator in Latin America from 2004 until January 2015. In 2012, he was named Voluntary Assistant Professor of Ophthalmology at the Miller School of Medicine, University of Miami and one year later the Director of Outreach Activities of the Department of Ophthalmology of the University of Tennesee. More recently, he joined Help Me See as the chief medical officer for Latin America and with time seconded as Residency Training Director of the Mexican Institute of Ophthalmology (IMO) in Queretaro, Mexico.
Diane Bovenkamp, PhD
Vice President, Scientific Affairs
Private/Non-Profit Funding Opportunities for Early-Career Scientists
Diane Bovenkamp, PhD, vice president, scientific affairs oversees all of BrightFocus' research programs, serves as the scientific liaison for the organization in local, national, and international forums, and identifies and develops new research initiatives, partnerships, and funding policies consistent with the mission of BrightFocus. Dr. Bovenkamp obtained her PhD in biochemistry from Queen's University in Kingston, Ontario, Canada, completed a postdoctoral fellowship in the vascular biology program at Boston Children's Hospital/Harvard Medical School, and conducted further research at the Johns Hopkins University Bayview Proteomics Center in the division of cardiology at Johns Hopkins School of Medicine in Baltimore, Maryland.
Table C - SOLD OUT
Philip I. Murray, PhD, FRCP, FRCS, FRCOphth
Professor of Ophthalmology
University of Birmingham
Institute of Inflammation and Ageing
Academic Unit of Ophthalmology
Birmingham and Midland Eye Centre
Effective Communication: Tips for Presenting and Publishing
Philip I. Murray is professor of ophthalmology, University of Birmingham, UK. His main laboratory and clinical interest is uveitis. He is an advisor to three patient societies and runs a local patient involvement group in uveitis. He has supervised clinical and non-clinical PhD students, hundreds of ophthalmology residents, and has a passion for undergraduate education. He has written nearly 200 scientific papers, book chapters and edited a number of textbooks and has 30 years’ experience of poster and oral presentations. He is frequently an invited speaker at international meetings. He “plays” baritone sax in two bands and more information can be found at: www.pimurray.com
Pinakin Gunvant Davey OD, PhD
Professor of Optometry and Director of Research
College of Optometry
Western University of Health Sciences, Pomona California
Career Options after graduate and professional school: Academia, Industry or hybrid
Dr. Pinakin Gunvant Davey is a professor at Western University of Health Sciences, College of Optometry. He holds Doctor of Optometry degree from Southern College of Optometry and a PhD from Anglia Ruskin University in Cambridge, England, in the area of glaucoma. His post-doctoral research fellowship at University of Louisville was focused on improving imaging techniques in glaucoma. He has authored over 50 international publications, and has given over 150 conference and invited presentations both nationally and internationally. Dr. Davey research area is focused on retinal and optic nerve physiology and researches methods of improving vision in glaucoma and macular degeneration.
Haiyan Gong, MD, PhD
Professor of Ophthalmology, Anatomy and Neurobiology
Boston University School of Medicine
Transitioning from student to post-doc to faculty
Haiyan Gong, MD, PhD, is a professor of ophthalmology, anatomy and neurobiology at Boston University School of Medicine (BUSM). She received her PhD in anatomy and neurobiology from BUSM, completed post-doc training in ophthalmology, and became a faculty member at the same school. Dr. Gong is an expert on the physiology and morphology of trabecular outflow pathway and has published more than 60 scientific articles and 6 textbook chapters. Dr. Gong’s research is currently funded by NIH/National Eye Institute, BrightFocus Foundation and Massachusetts Lions Eye Research Fund.
Julia Busik, PhD
Professor of Physiology
Michigan State University
Your dream experiment just worked! What's next? How to sell it in papers and grants
Julia Busik, PhD, is professor of physiology at Michigan State University. She received her BS and MS degrees from Novosibirsk State University, USSR, and PhD from the Graduate University for Advanced Studies, Department of Physiology, Yokohama, Japan. Dr. Busik started research in the area of diabetic complications after joining Michigan State University as a post-doctoral fellow under the guidance of Dr. Douglas Henry. Dr. Busik has published over 50 papers in high profile journals and she is a well-recognized expert on the role of dyslipidemia in the development of diabetic complications. Dr. Busik has received the Carrier Development Award from the Juvenile Diabetes Research Foundation and numerous research awards from National Eye Institute and American Diabetes Association, among other awards. Dr. Busik was trained in the area of lipid metabolism by the leader of the field, Dr. Donald Jump. Realizing that limits in the sensitivity of available analytical methods prevented the development of lipidomic approach using limited retinal material, she started a collaboration with mass spectrometry expert Dr. Gavin Reid with the goal of developing a comprehensive lipidomic profiling approach to identify lipid pathways affected in diabetic retinopathy. This approach was successfully used to identify an important role of several lipid metabolic pathways in the retinas of diabetic animal model. Specifically Dr. Busik and her colleagues determined that downregulation of retinal fatty acid elongation in diabetes leading to pro-inflammatory fatty acid profile changes with a decrease in the most abundant retinal n3 polyunsaturated fatty acid, docosahexaenoic acid (DHA). Moreover, they demonstrated dramatic upregulation of the central enzyme in sphingolipid metabolism, acid sphingomyelinase in the diabetic retina. Correction of diabetes-induced lipid profile changes with DHA supplementation dramatically inhibited activation of acid sphingomyelinase and vascular pathology in diabetic retina. Recently, Dr. Busik started collaboration with Dr. Denis Proshlyakov’s laboratory to determine the role of acid sphingomyelinase and increased ceramide production in mitochondrial damage in diabetic retina.
Katrina Schmid, PhD
Associate Professor, School of Optometry and Vision Science, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology
Developing your teaching portfolio
Dr. Katrina Schmid is an associate professor within the School of Optometry and Vision Science at QUT, Brisbane, Australia, where she is course co-ordinator of the Bachelor of Vision Science. She is research and teaching optometrist with a PhD in optometry and an H-index of 24; with more than 90 full research articles and over 2000 citations. She is a member of the ARVO Animal Research Committee. She is a Senior Fellow of the Higher Education Academy; the success of her application was based on her mentoring of others in their pursuit of teaching excellence.
Randy Kardon, MD, PhD, FARVO
Professor of Ophthalmology, director, Neuro-ophthalmology Service
University of Iowa and Veterans Administration Hospitals
Can I Still Have it All? How to Successfully Combine Clinical Ophthalmology and Research and Still be Fully Funded in 2018
Randy Kardon MD PhD, an Iowa native, is tenured professor of ophthalmology and director of the Neuro-ophthalmology Service at the University of Iowa and Veterans Administration Hospitals. He holds the Pomerantz Family Chair in Ophthalmology and is director of the Iowa City Veterans Administration Center of Excellence for the Prevention and Treatment of Visual Loss. Dr. Kardon has published over 20 chapters, co-authored a textbook, published over 200 peer-reviewed journal articles, and is presently the principle investigator or co-PI on 6 major grants externally funded by the Veterans Administration, NIH, and the Department of Defense. He has had funding for his research from the Department of Veterans Affairs since 1990, and was one of the first ophthalmologists to receive a VA Career Development Award. His main areas of current research interest include pupil physiology and clinical application, traumatic brain injury and its treatment, structure-function relationships in optic nerve disease, ocular blood flow, image analysis and telemedicine of the retina and optic nerve.
Thomas W. Gardner, MD, MS
Professor of Ophthalmology and Visual Sciences,
Molecular and Integrative Physiology, and Internal Medicine.
University of Michigan Medical School
Dr. Gardner is a clinician-scientist whose work focuses on the pathophysiology and treatment of diabetic retinopathy. He collaborates with multiple colleagues on clinic- and laboratory-based studies, and maintains an active practice. He has worked with NIH and multiple foundations regarding strategies for diabetes research and practice. He is associate chair for research at the Kellogg Eye Center.
Table J - SOLD OUT
Mark Radford, MD, PhD, FRANZCO
Executive Director and Chief Executive Officer
Queensland Eye Institute
Thinking outside the box: Alternative Careers for the Clinician Scientist or Researcher
Prof. Mark Radford has been executive director and chief executive officer for the Queensland Eye Institute since March 2010 and the South Bank Day Hospital since December 2013. Mark completed his first undergraduate degree at Flinders University of South Australia in 1978. After being awarded a Japanese Government (Mombusho) Fellowship, Mark completed his Doctor of Medicine at Nagasaki University School of Medicine in 1992. During this period he also completed a PhD at Flinders University (1989). Mark started his working career as a research academic (lecturer and later Associate Professor) at Hokkaido University in Japan. Between 1993 and 2003, Mark served as a consultant to a number of government and private organisations worldwide, before returning to Hokkaido University to become Professor within the Department of Behavioural Science. In 2006, Mark returned to Australia to become CEO and Managing Director of Symbiosis Group Limited — a life science investment, management and commercialization company based in Brisbane, Australia. Mark has extensive experience in medical research, teaching and management. He has published extensively in the area of medicine, culture and behavior, leadership and decision-making. Mark is a member of a number of professional associations. Mark is a Fellow (Hon) of the Royal Australian and New Zealand College of Opthalmologists, and also the Australian Institute of Company Directors (AICD) and Australian Institute of Management (AIM).
Maureen G. Maguire, PhD
Carolyn F. Jones Professor of Ophthalmology
University of Pennsylvania
How do I fit in and thrive? For biostatisticians and epidemiologists in vision research
Maureen G. Maguire, PhD, is the Carolyn F. Jones Professor of Ophthalmology at the University of Pennsylvania and holds a secondary appointment in the Department of Biostatistics, Epidemiology and Informatics. Maureen started her career in ophthalmology as an MS biostatistician at the Johns Hopkins Wilmer Institute while pursuing her doctoral degree. She later founded the Center for Preventive Ophthalmology and Biostatistics at the University of Pennsylvania. She has led the coordinating center for several multicenter clinical trials and enjoys biostatistical consulting with students and faculty.
Xiaoying Zhu, OD, MD, PhD, MS, FAAO
Assistant Clinical Professor
Biological and Vision Sciences
Developing a Career as a Clinician Scientist
Dr. Xiaoying Zhu’s principal research interests encompass emmetropization, visual development and myopia. She received her MD from China Medical University, OD from New England College of Optometry, and PhD from University of Newcastle. Shi is currently the lead clinician at the Myopia Control Clinic at SUNY, College of Optometry. She has been conducting basic and clinical research over the years to come up with novel, economical, practical and effective methods to prevent and/or slow down myopia progression in children.
Table M - SOLD OUT
Ann Logan BSc, PGCE, PhD
Institute of Inflammation and Aging, University of Birmingham
Professor of Molecular Neuroscience
Setting up spinoffs and conducting commercial research from an academic lab
Professor Ann Logan received her BSc from the University of London in 1974 and PhD training in neuroendocrinology at the University of Birmingham between 1975 and 1978. After post-doctoral training at the University of Leeds and in the laboratories of Professor Roger Guillemin and Professor Andrew Baird at Scripps Hospital, La Jolla, CA, she established the Neurotrauma Group at the University of Birmingham in 1990, where she is currently Professor of Molecular Neuroscience and Head of the Neurotrauma Research Group within the College of Medicine and Dentistry. Her research interests centre upon the trophic regulation of injury responses. Her work has generated more than 185 research publications on the roles, mechanisms and exploitation of growth factors in the injured tissues, with particular interests in neurotrauma of the eye. Professor Logan strives to translate scientific advancements into the clinical arena for patient benefit. For her own research she works closely with both clinicians and companies to initiate clinical trials of novel anti-scarring and reparative drugs. In 2011 a £20M NIHR Surgical Reconstruction and Microbiology Research Centre was opened in Birmingham that incorporates the Royal Centre for Defence Medicine. Within this Centre Ann leads the Regenerative and Reconstructive Medicine research team and is PI for a number of major £multi-million translational projects related to the clinical development of anti-scarring technologies. This unique multidisciplinary grouping of academics with civilian and military clinician researchers provides an unrivaled opportunity to promote trauma research for patient benefit in the UK. In addition, she is also founder, director and CSO for a University of Birmingham spin-out company called Neuregenix Ltd, that offers neural drug screening services to large and small pharmaceutical and biotechnology companies.
Table N - SOLD OUT
Miller J. Ogidigben, PhD, FARVO
MSL Regional Director - Eye Care
Allergan Medical Affair
Careers in Industry
Dr. Ogidigben is a medical scientific executive with 17+ years of drug development experience, and strategic clinical trial tactical implementation at three Fortune 500 pharmaceutical companies. Dr. Ogidigben holds 4 patents in ophthalmology and directed two drug discoveries to clinical trials. Dr. Ogidigben is currently director on the Medical Science Liaison (MSL) team within Allergan Medical Affairs, responsible for establishing and maintaining professional relationships with key thought-leaders, to provide regional scientific services as the liaison between industry, medical and scientific research. Dr. Ogidigben served as member of ARVO Science Pillar Steering Committee, Chair Translational Science Working Group, and an ARVO Developing Country Fellowship Program Mentor.
Robert AH Scott MBBS, FRCS(Ed), FRCOphth, DM
Medical Director, SpaMedica
Professor of Ophthalmology, University of Birmingham
Connecting clinical practice with research
Professor Robert Scott is the medical director of SpaMedica, the largest cataract surgery provider in the UK and is supervising expansion of its services throughout the UK. He is an honorary Professor of Ophthalmology at the University of Birmingham with a research focus around ocular trauma and scarring. He was recently medical director for Moorfields Eye Hospital in Dubai garnering experience of the healthcare environment in the UAE. As a consultant ophthalmologist, his subspecialty interests are in vitreoretinal and cataract surgery. He qualified and trained in ophthalmology in the UK and spent 26 years in the RAF where his work treating soldiers with eye injuries from Iraq and Afghanistan was featured on the acclaimed BBC documentary ‘Frontline Medicine’. His research is widely published in the scientific press and he was appointed as the Defence Medical Services Professor of Ophthalmology in 2011. He was honoured as a 'Times' top all specialty UK surgeon in 2011 and awarded the Lady Cade Medal for research by the Royal College of Surgeons of England. He continues his work for good causes that help blind service veterans.
Tonia S. Rex, PhD
Department of Ophthalmology and Visual Sciences
Vanderbilt Eye Institute
Balancing Family and career
Dr. Tonia Rex is an associate professor in the Vanderbilt Eye Institute at Vanderbilt University Medical Center where she is also the director of Resident Research and is co-director of the Gene and Protein Analysis Module in the Vanderbilt Vision Research Center. Dr. Rex was awarded the Hope for Vision Young Investigator Award, the Shaffer Prize for Innovative Glaucoma Research from the Glaucoma Research Foundation, and the Research to Prevent Blindness Career Development Award. She is funded by the NEI and the DoD to investigate mechanisms and therapeutic strategies in glaucoma and ocular trauma, respectively.
Table Q - SOLD OUT
Jacque L. Duncan, MD
Department of Ophthalmology
University of California, San Francisco
Applying to Ophthalmology Residency Programs
Jacque L. Duncan, MD, served on the Residency Selection Committee from 2005-2013, and has been the vice chair for medical student affairs in the ophthalmology department at UCSF since 2010. She completed her internship and residency in ophthalmology at UCSF before going to the University of Pennsylvania to complete a fellowship in medical retina, specializing in inherited retinal degenerations and age-related macular degeneration. Dr. Duncan returned to UCSF to join the faculty in 2000. During and since that time, she has developed a retinal degenerations clinic at UCSF and initiated a research program in collaboration with Austin Roorda,PhD, at UC Berkeley School of Optometry, using high-resolution imaging techniques to study cone photoreceptor structure in the eyes of living patients with inherited retinal degenerations.
Joel S. Schuman, MD, FARVO
Professor and Chair, Department of Opthalmology
Professor, Department of Neuroscience and Physiology
NYU Langone Health, New York
Professor, Electrical & Computer Engineering
NYU Tandon School of Engineering, New Yorkk
Maximizing Scientific Achievment
Joel S. Schuman, MD, is Professor and Chairman of Ophthalmology and Professor of Neuroscience and Physiology at NYU Langone Health and Professor of Electrical & Computer Engineering at NYU Tandon School of Engineering. Dr. Schuman and colleagues were first to identify a molecular marker for human glaucoma. Continuously funded by the NIH as a principal investigator since 1995, he is an inventor of optical coherence tomography (OCT). He has published more than 400 peer-reviewed scientific articles.
Subhabrata Chakrabarti, PhD
Associate Director (Research)
L.V. Prasad Eye Institute
Choosing your Niche in Research
Dr. Subhabrata Chakrabarti, associate director of research at the L V Prasad Eye Institute (LVPEI), is a genome biologist with primary focus on the functional genomics of glaucoma. His works have provided some novel insights that are recognized through the 'Research Recognition Award' of the World Glaucoma Association, Affiliateship of all Science Academies of India and The World Academy of Sciences (TWAS). He has published widely, secured extramural research grants and currently serves on the Editorial Boards of TVST, Molecular Vision, Journal of Glaucoma and also on the Strategic Planning, Research Training and Professional Development and Education Committees of ARVO.
Larry Benowitz, PhD
Professor of Neurosurgery and Ophthalmology,
Harvard Medical School
Neurosurgical Innovation and Research Endowed Professor,
Boston Children's Hospital
Running a Successful Research Lab
Larry Benowitz received his PhD from Caltech with Nobel Laureate Roger Sperry and did postdoctoral fellowships at MIT and Harvard Medical School before joining the Harvard faculty, where he has worked for many years studying plasticity and regeneration of CNS connections. In recent years, working at Boston Children’s Hospital, his research has focused primarily on regeneration of the optic nerve, studying growth factors associated with inflammation, signal transduction pathways, transcriptional regulators, and combinatorial therapies to promote optic nerve regeneration, along with the role of TNF-alpha in glaucoma. Drs. Benowitz, Yiqing Li, and Paul Rosenberg recently discovered an inter-cellular signaling network through which interneurons and glia influence the survival of retinal ganglion cells and optic nerve regeneration following optic nerve injury through the elevation of mobile zinc and other non-conventional signals. In 2006, Dr. Benowitz was named by Scientific American as one of the 50 leaders of the year in science and technology, and in 2013 he was awarded the Lewis Rudin Prize for “the most significant scholarly article on glaucoma published in a peer-reviewed journal in the prior calendar year”. He currently holds the Neurosurgical Innovation and Research Professorship at Boston Children’s Hospital and is a Professor of Neurosurgery and Ophthalmology at Harvard Medical School.